Sodium-Glucose Transporter 1, antagonists & inhibitors

Name

Sodium-Glucose Transporter 1, antagonists & inhibitors

Accession Number

DBCAT003084

Description

Not Available

Drugs

Drug	Drug Description
Sotagliflozin	An orally administered dual SGLT1/2 inhibitor used alongside insulin to improve glycemic control in patients with type 1 diabetes mellitus.

Drugs & Drug Targets

Drug	Target	Type
Sotagliflozin	UDP-glucuronosyltransferase 1-9	enzyme
Sotagliflozin	UDP-glucuronosyltransferase 1-1	enzyme
Sotagliflozin	UDP-glucuronosyltransferase 2B7	enzyme
Sotagliflozin	Cytochrome P450 3A4	enzyme
Sotagliflozin	Sodium/glucose cotransporter 2	target
Sotagliflozin	Sodium/glucose cotransporter 1	target
Sotagliflozin	Cytochrome P450 2D6	enzyme
Sotagliflozin	P-glycoprotein 1	transporter
Sotagliflozin	ATP-binding cassette sub-family G member 2	transporter
Sotagliflozin	Solute carrier organic anion transporter family member 1B1	transporter
Sotagliflozin	Solute carrier organic anion transporter family member 1B3	transporter
Sotagliflozin	Canalicular multispecific organic anion transporter 1	transporter